Becker M A, Losman M J, Itkin P, Simkin P A
J Lab Clin Med. 1982 Apr;99(4):495-511.
We have studied families C and A in which superactivity of PRPP synthetase (E.C. 2.7.6.1) is associated with gout and uric acid overproduction in affected hemizygous males. PRPP synthetase catalyzes synthesis of PRPP, a regulatory substrate in purine synthesis de novo. Activities of the enzyme in erythrocyte and fibroblast extracts from the male index cases, T.C. and R.A., were nearly threefold greater than normal at each Pi concentration tested. PRPP synthetase superactivity was accompanied by increased intracellular PRPP concentration and generation in erythrocytes and fibroblasts from these patients, and enhanced rates of PRPP-dependent purine synthesis reactions, including purine synthesis de novo, were demonstrable in their fibroblasts. These findings suggested that increased intracellular synthesis dut to enzyme superactivity underlay purine nucleotide and uric acid overproduction in these patients. Similar studies in cells from the sister of T.C. and the mother of R.A. showed increased values that were, however, intermediate between normal values and those of the affected males, indicating that these women are heterozygous carriers of the traits for enzyme superactivity. The enzymatic basis for increased PRPP synthetase activity in both families was investigated. Immunochemical studies in dialyzed erythrocyte lysates and highly purified erythrocyte enzyme preparations provided evidence for increased enzyme activity per molecule of immunoreactive enzyme. In addition, purified T.C. and R.A. PRPP synthetases showed 3.1- and 2.8-fold greater enzyme specific activities, respectively, than comparably purified normal enzymes. Kinetic constants of purified T.C. and R.A. PRPP synthetases for substrates, activators, and inhibitors were indistinguishable from normal, and increased maximal reaction velocity alone appeared to account for enzyme superactivity. Despite an apparently similar kinetic mechanism for superactivity, the diminished electrophoretic mobility of T.C. PRPP synthetase and increased thermal lability of R.A. PRPP synthetase suggested distinct structural alterations leading to enzyme superactivity in families C and A.
我们研究了C家族和A家族,在这些家族中,磷酸核糖焦磷酸合成酶(E.C. 2.7.6.1)的超活性与受影响的半合子男性痛风和尿酸过度生成有关。磷酸核糖焦磷酸合成酶催化磷酸核糖焦磷酸(PRPP)的合成,PRPP是嘌呤从头合成中的一种调节性底物。在男性索引病例T.C.和R.A.的红细胞和成纤维细胞提取物中,该酶在每个测试的无机磷酸(Pi)浓度下的活性几乎比正常情况高三倍。PRPP合成酶超活性伴随着这些患者红细胞和成纤维细胞中细胞内PRPP浓度的增加和生成,并且在他们的成纤维细胞中可证明PRPP依赖性嘌呤合成反应速率的提高,包括嘌呤从头合成。这些发现表明,酶超活性导致的细胞内合成增加是这些患者嘌呤核苷酸和尿酸过度生成的基础。对T.C.的妹妹和R.A.的母亲的细胞进行的类似研究显示,数值增加,但介于正常值和受影响男性的值之间,表明这些女性是酶超活性性状的杂合携带者。对两个家族中PRPP合成酶活性增加的酶学基础进行了研究。对透析后的红细胞裂解物和高度纯化的红细胞酶制剂进行的免疫化学研究提供了证据,表明每分子免疫反应性酶的酶活性增加。此外,纯化的T.C.和R.A.的PRPP合成酶的酶比活性分别比同等纯化的正常酶高3.1倍和2.8倍。纯化的T.C.和R.A.的PRPP合成酶对底物、激活剂和抑制剂的动力学常数与正常情况没有区别,似乎仅最大反应速度的增加就导致了酶超活性。尽管超活性的动力学机制明显相似,但T.C.的PRPP合成酶电泳迁移率降低,而R.A.的PRPP合成酶热稳定性增加,这表明在C家族和A家族中导致酶超活性的结构改变不同。